| P2093 | author name string | Wei Zhang | |
| | Tao Jiang | |
| | Daniel Hänggi | |
| | Sajjad Muhammad | |
| | Hans-Jakob Steiger | |
| | Ann-Christin Nickel | |
| | Marcel Alexander Kamp | |
| | Guanzhang Li | |
| | Julia Tsiampali | |
| | Ulf Dietrich Kahlert | |
| | Dilaware Khan | |
| | Jarek Maciaczyk | |
| | Michael Hewera | |
| | Philippe Aretz | |
| | Abiagail Kora Suwala | |
| | Dayana Herrera-Rios | |
| P2860 | cites work | U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line | Q21144984 |
| | Lentiviral vectors to probe and manipulate the Wnt signaling pathway | Q28472995 |
| | Biological network exploration with Cytoscape 3 | Q28655509 |
| | Cancer statistics, 2016 | Q29547383 |
| | The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 |
| | A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen | Q29615061 |
| | GSVA: gene set variation analysis for microarray and RNA-seq data. | Q30586230 |
| | Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors | Q33252671 |
| | γ-Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence | Q34101839 |
| | Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres. | Q34363706 |
| | The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. | Q34688196 |
| | MicroRNA-146a inhibits glioma development by targeting Notch1 | Q35192143 |
| | Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas | Q35587229 |
| | ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres. | Q35752332 |
| | Cancer stem cells in glioblastoma | Q35829972 |
| | Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update | Q35904534 |
| | Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance | Q36361024 |
| | Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells | Q36633528 |
| | Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. | Q36884210 |
| | A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells | Q37626395 |
| | Therapeutic modulation of Notch signalling--are we there yet? | Q38208211 |
| | Wnt-Notch signalling crosstalk in development and disease. | Q38221361 |
| | EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities. | Q38677439 |
| | Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells | Q38848185 |
| | Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways | Q38889490 |
| | Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells | Q38988209 |
| | Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors | Q39168179 |
| | Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. | Q39339148 |
| | Notch1 signaling promotes survival of glioblastoma cells via EGFR-mediated induction of anti-apoptotic Mcl-1. | Q39411406 |
| | Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation | Q39441568 |
| | Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial. | Q39786861 |
| | Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel | Q39965737 |
| | Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells | Q42317550 |
| | Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. | Q42371488 |
| | Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples | Q42777737 |
| | Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts. | Q45735200 |
| | Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells | Q47337253 |
| | Oxidative stress preconditioning of mouse perivascular myogenic progenitors selects a subpopulation of cells with a distinct survival advantage in vitro and in vivo. | Q48314148 |
| | Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway. | Q50148579 |
| | Current Challenges and Opportunities in Treating Glioblastoma. | Q52579808 |
| | Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro. | Q55347904 |
| | New approach for understanding genome variations in KEGG | Q57469392 |
| | Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma | Q58693796 |
| | ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma | Q59789226 |
| | Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment | Q64110008 |
| | A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer | Q64123499 |
| | PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor. | Q64883722 |
| | A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors | Q88568839 |
| | Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival | Q88954080 |
| | Adult Human Glioblastomas Harbor Radial Glia-like Cells | Q89467912 |
| | NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling | Q91660537 |
| | GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic Profile | Q91863469 |
| | An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma | Q92055634 |
| | Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma | Q92413099 |
| | Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4 | Q92425093 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| | GSVA | Q113334751 |
| P433 | issue | 1 | |
| P304 | page(s) | 16218 | |
| P577 | publication date | 2020-10-01 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma | |
| P478 | volume | 10 | |